Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib
- Publisher
- BREAST CANCER RESEARCH AND TREATMENT
- Language
- 영어
- ISSN
- 0167-6806
- Citation Volume
- 184
- Citation Number
- 3
- Citation Start Page
- 743
- Citation End Page
- 753
-
Appears in Collections:
- Medicine > Medicine
- Authorize & License
-
- Files in This Item:
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.